Standout Papers

Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, p... 2009 2026 2014 2020 1.2k
  1. Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6) (2009)
    John B. Buse, Julio Rosenstock et al. The Lancet

Citation Impact

1 by Nobel laureates 5 from Science/Nature 90 standout
Sub-graph 1 of 20

Citing Papers

Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes
2024 Standout
Dissociable hindbrain GLP1R circuits for satiety and aversion
2024 StandoutNature
6 intermediate papers

Works of Marcin Zychma being referenced

Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6)
2009 Standout

Author Peers

Author EDM Molecular Biology CCM Surgery Last Decade Papers Cites
Marcin Zychma 1420 780 142 550 24 1.7k
М. И. Правдин 70 447
Vyacheslav Karpov 15 300
Ann‐Kristin Ulfgren 45 601 173 219 30 3.2k
F. Dehout 2 99 48 18 13 963
Mitsuaki Moriguchi 43 1234 2 11 86 1.7k

All Works

Loading papers...

Rankless by CCL
2026